GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Aurisco Pharmaceutical Co Ltd (SHSE:605116) » Definitions » Total Operating Expense

Aurisco Pharmaceutical Co (SHSE:605116) Total Operating Expense : ¥428 Mil (TTM As of Mar. 2024)


View and export this data going back to 2020. Start your Free Trial

What is Aurisco Pharmaceutical Co Total Operating Expense?

Aurisco Pharmaceutical Co's Total Operating Expense for the three months ended in Mar. 2024 was ¥92 Mil. Aurisco Pharmaceutical Co's Total Operating Expense for the trailing twelve months (TTM) ended in Mar. 2024 was ¥428 Mil.

Aurisco Pharmaceutical Co Total Operating Expense Historical Data

The historical data trend for Aurisco Pharmaceutical Co's Total Operating Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Aurisco Pharmaceutical Co Total Operating Expense Chart

Aurisco Pharmaceutical Co Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Total Operating Expense
Get a 7-Day Free Trial 129.03 142.13 202.44 292.05 409.35

Aurisco Pharmaceutical Co Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Total Operating Expense Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 73.72 90.19 120.58 124.86 92.15

Aurisco Pharmaceutical Co Total Operating Expense Calculation

Total Operating Expense is the primary recurring expense associated with central operations that are incurred in order to generate sales.


Total Operating Expense for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥428 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Aurisco Pharmaceutical Co Total Operating Expense Related Terms

Thank you for viewing the detailed overview of Aurisco Pharmaceutical Co's Total Operating Expense provided by GuruFocus.com. Please click on the following links to see related term pages.

Aurisco Pharmaceutical Co (SHSE:605116) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Aurisco Pharmaceutical Co Ltd (SHSE:605116) » Definitions » Total Operating Expense
Comparable Companies
SZSE:300049 SHSE:688202 SHSE:600645 SZSE:300841 SHSE:688382 SHSE:688315 SZSE:000990 SHSE:688526 SHSE:603229 SHSE:600201 OCSE:NOVO B VRTX REGN ASX:CSL SGEN XKRX:207940 MRNA HKSE:02269 XBRU:ARGX BNTX
Traded in Other Exchanges
N/A
Address
Badu Industrial Park, Tiantai County, Zhejiang Province, Taizhou, CHN, 317200
Website
http://www.aurisco.com
Aurisco Pharmaceutical Co Ltd is engaged in production and sales of specialty APIs and pharmaceutical intermediates. The company's products include API's and Intermediates. Its products are supplied to Asia, Europe, America and Middle East through a well-established sales network.

Aurisco Pharmaceutical Co (SHSE:605116) Headlines

No Headlines